Inflammatory bowel disease is frequently associated with liver disease. This review covers the most common causes of hepatobiliary disease in IBD patients, including PSC, AIH, overlap syndrome and ...

The study of liver disease models, drug screening, and toxicity assessment has been hindered by the lack of faithful representations of liver models. This work unveiled key signaling pathways in ...

Inflammatory bowel disease (IBD) is a chronic condition with significant health implications worldwide. In Nigeria, data on its prevalence and characteristics are limited, highlighting the need for ...

Rectify Pharmaceuticals Inc. has conducted preclinical testing on RTY-694, an oral dual-targeted positive functional modulator for use in the treatment of hepatobiliary disorders.

The data will showcase the potential of a novel ABCB4/BSEP dual-targeting oral small molecule PFM to treat primary sclerosing cholangitis (PSC) and other hepatobiliary diseases.

The articles listed below published by authors from Hepatobiliary Disease Hospital of Jilin Province, organized by journal and article, represent the research output in Count and Share according ...

Cite this: Hepatobiliary Associations with Inflammatory Bowel Disease - Medscape - Dec 01, 2009.